Key result
Gadolinium-enhanced CMR reveals midwall fibrosis in a patient with chemotoxic cardiomyopathy.
Gadolinium-enhanced CMR can identify midwall fibrosis or myocardial cell loss in patients with chemotoxic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
May identify midwall fibrosis via CMR in chemotoxic cardiomyopathy; hypothesis-generating and should not yet change practice.
Gadolinium-enhanced cardiac magnetic resonance was performed in a patient with chemotoxic cardiomyopathy. Intramyocardial midwall linear delayed hyperenhancement was found. Such a finding is consistent with midwall fibrosis and/or myocardial cell loss due to cardiotoxic effect of chemotherapy.
No takes yet. Share an insight, caveat, or question.
Catalano et al. (2007) studied this question. Gadolinium-enhanced cardiac magnetic resonance revealed intramyocardial midwall linear delayed hyperenhancement indicating fibrosis in a patient with chemotoxic cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: